Financial Sector (Collection of Data) (reporting standard) determination No. 9 of 2026Reporting Standard ARS 221.0 Large ExposuresFinancial Sector (Collection of Data) Act 2001I, Andrew Robertson, delegate of APRA, under paragraph 13(1)(a) of the Financial Sector (Collection of Data) Act 2001 (the Act) and subsection 33(3) of the Acts Interpretation Act 1901:revoke Financial Sector (Collection of Data) (reporting standard) determination No. 55 of 2023, including Reporting Standard ARS 221.0 Large Exposures made under that determination; anddetermine Reporting Standard ARS 221.0 Large Exposures, in the form set out in the Schedule, which applies to the financial sector entities to the extent provided in paragraph 3 of that reporting standard.Under section 15 of the Act, I declare that Reporting Standard ARS 221.0 Large Exposures shall begin to apply to those financial sector entities, and the revoked reporting standard shall cease to apply, at the start of the day after this instrument is registered on the Federal Register of Legislation.This instrument commences at the start of the day after it is registered on the Federal Register of Legislation.Dated: 22 September 2026Andrew RobertsonGeneral Manager - Chief Data OfficerTechnology and Data DivisionInterpretationIn this Determination:APRA means the Australian Prudential Regulation Authority.Federal Register of Legislation means the register established under section 15A of the Legislation Act 2003.financial sector entity means financial sector entities of a kind referred to in paragraphs 5(2)(a) to (d) of the Act.Schedule Reporting Standard ARS 221.0 Large Exposures comprises the document commencing on the following page.
Section A: Large exposures Item 1Report the twenty largest exposures and all large exposures, as at the end of the reporting period. That is, report the twenty largest exposures regardless of their size in proportion to Common Equity Tier 1 Capital, and also report all exposures which exceed or are equal to ten per cent of Common Equity Tier 1 Capital.In column 1, report the counterparty name of the counterparty for each exposure or the group counterparty name if the exposure is to a group of connected counterparties.In column 2, report the Legal Entity Identifier of the counterparty for each exposure or the Legal Entity Identifier of the principal counterparty if the exposure is to a group of connected counterparties. Otherwise, report N/A if the counterparty or principal counterparty has no Legal Entity Identifier.In column 3, report the counterparty sector of the counterparty or the principal counterparty of a group of connected counterparties for each exposure.In column 4, report the on-balance sheet exposures relating to the book value of all loans and advances to the counterparty for each exposure, including any accrued income associated with the exposure (e.g. interest, dividends).In column 5, report the on-balance sheet exposures not relating to loans and advances to the counterparty for each exposure.In column 6, report the non-market related, off-balance sheet exposures for the counterparty for each exposure.In column 7, report the market related, off-balance sheet exposures for the counterparty for each exposure.Column 8 is derived as the total of columns 4, 5, 6 and 7, being the total exposure for the counterparty.Column 9 is derived as the ratio of column 8 to Common Equity Tier 1 Capital reported in item 7.Item 1.1Item 1.1 is derived as the total of the twenty largest exposures and all large exposures.Columns 4, 5, 6, 7 and 8 of item 1.1 are derived as the sum of columns 4, 5, 6, 7 and 8 of item 1 respectively.Column 9 of item 1.1 is derived as the ratio of column 8 of item 1.1 to Common Equity Tier 1 Capital reported in item 7.Item 2Report in item 2 details of each group of connected counterparties reported in Item 1. Each counterparty within each group of connected counterparties reported in item 1 should be reported on a separate row in item 2.In column 1, report the group counterparty name for each counterparty within each group of connected counterparties reported in item 1.In column 2, report the connection between the counterparty and the group of connected counterparties.In column 3, report the counterparty name of each counterparty within each group of connected counterparties reported in item 1.Item 3Report the twenty largest exposures and exposures exceeding or equal to five per cent of Common Equity Tier 1 Capital to government-related entities, as at the end of the reporting period. Do not group exposures into groups of connected counterparties.In column 1, report the counterparty name of the government-related entity for each exposure.In column 2, report the Legal Entity Identifier of the counterparty for each exposure if the government-related entity has one. Otherwise, report N/A if the government-related entity has no Legal Entity Identifier.In column 3, report the counterparty country of the government-related entity for each exposure.In column 4, report the counterparty sector of the government-related entity for each exposure.In column 5, report the on-balance sheet exposures relating to the book value of all loans and advances to the government-related entity for each exposure, including any accrued income associated with the exposure (e.g. interest, dividends).In column 6, report the on-balance sheet exposures not relating to loans and advances to the government-related entity for each exposure.In column 7, report the non-market related, off-balance sheet exposures for the government-related entity for each exposure.In column 8, report the market related, off-balance sheet exposures for the government-related entity for each exposure.Column 9 is derived as the total of columns 5, 6, 7 and 8, being the total exposure for the government-related entity.Column 10 is derived as the ratio of column 9 to Common Equity Tier 1 Capital reported in item 7.Item 3.1Item 3.1 is derived as the total of the twenty largest exposures for government-related entities and all exposures for government-related entities which exceed or are equal to five per cent of Common Equity Tier 1 Capital.Columns 5, 6, 7, 8 and 9 of item 3.1 are derived as the sum of columns 5, 6, 7, 8 and 9 of item 3 respectively.Column 10 of item 3.1 is derived as the ratio of column 9 of item 3.1 to Common Equity Tier 1 Capital reported in item 7.Section B: Large exposures (without credit risk mitigation effects)Item 4Report the twenty largest exposures and all large exposures as at the end of the reporting period, measured before the impact of CRM. That is, report the twenty largest exposures regardless of their size in proportion to Common Equity Tier 1 Capital and also report all exposures which exceed or are equal to ten per cent of Common Equity Tier 1 Capital, before CRM.The removal of the impact of CRM may mean the exposures listed in item 4 might not be the same as those in item 1.In column 1, report the counterparty name of the counterparty or the group counterparty name for each exposure.In column 2, report the Legal Entity Identifier of the counterparty for each exposure or the Legal Entity Identifier of the principal counterparty if the exposure is to a group of connected counterparties. Otherwise, report N/A if the counterparty or principal counterparty has no Legal Entity Identifier.In column 3, report the counterparty sector of the counterparty or the principal counterparty of a group of connected counterparties for each exposure.In column 4, report the on-balance sheet exposures relating to the book value of all loans and advances to the counterparty for each exposure, including any accrued income associated with the exposure (e.g. interest, dividends), before CRM.In column 5, report the on-balance sheet exposures not relating to loans and advances to the counterparty for each exposure, before CRM.In column 6, report the non-market related, off-balance sheet exposures for the counterparty for each exposure, before CRM.In column 7, report the market related, off-balance sheet exposures for the counterparty for each exposure, before CRM.Column 8 is derived as the total of columns 4, 5, 6 and 7, being the total exposure for the counterparty, before CRM.Column 9 is derived as the ratio of column 8 to Common Equity Tier 1 Capital reported in item 7.Item 4.1Item 4.1 is derived as the total of the twenty largest exposures and all large exposures, before CRM.Columns 4, 5, 6, 7 and 8 of item 4.1 are derived as the sum of columns 4, 5, 6, 7 and 8 of item 4 respectively.Column 9 of item 4.1 is derived as the ratio of column 8 of item 4.1 to Common Equity Tier 1 Capital reported in item 7.Item 5Report in item 5 details of each group of connected counterparties reported in Item 4 that were not reported in item 1. Each counterparty within each group of connected counterparties reported in item 4 should be reported on a separate row in item 5, unless it was already reported in item 1.In column 1, report the group counterparty name for each counterparty within each group of connected counterparties reported in item 4.In column 2, report the connection between the counterparty and the group of connected counterparties.In column 3, report the counterparty name of each counterparty within each group of connected counterparties reported in item 4.Section C: Excluded exposuresItem 6Report all excluded exposures exceeding or equal to ten per cent of Common Equity Tier 1 Capital that are sovereigns held as HQLA, to QCCPs relating to clearing activities, and settlement exposures as at the end of the reporting period. If the excluded exposure to a counterparty relates to more than one exclusion category, report the excluded exposure under a separate row in item 6 with the relevant counterparty and all relevant exclusion categories.Do not group exposures into groups of connected counterparties. Do not include any other type of excluded exposure.In column 1, report the counterparty name of the counterparty for each excluded exposure.In column 2, report the Legal Entity Identifier of the counterparty for each excluded exposure if the counterparty has one. Otherwise, report N/A if the counterparty has no Legal Entity Identifier.In column 3, report the counterparty sector of the counterparty for each excluded exposure.In column 4, report the exclusion category for each excluded exposure.In column 5, report the on-balance sheet exposures relating to the book value of all loans and advances to the counterparty for each excluded exposure, including any accrued income associated with the excluded exposure (e.g. interest, dividends).In column 6, report the on-balance sheet exposures not relating to loans and advances to the counterparty for each excluded exposure.In column 7, report the non-market related, off-balance sheet exposures for the counterparty for each excluded exposure.In column 8, report the market related, off-balance sheet exposures for the counterparty for each excluded exposure.Column 9 is derived as the total of columns 5, 6, 7 and 8, being the total exposure for the counterparty.Column 10 is derived as the ratio of column 9 to Common Equity Tier 1 Capital reported in item 7.Item 6.1Item 6.1 is derived as the total of the excluded exposures exceeding or equal to ten per cent of Common Equity Tier 1 Capital that are sovereigns held as HQLA, to QCCPs relating to clearing activities, and settlement exposures.Columns 5, 6, 7, 8 and 9 of item 6.1 are derived as the sum of columns 5, 6, 7, 8 and 9 of item 6 respectively.Column 10 of item 6.1 is derived as the ratio of column 9 of item 6.1 to Common Equity Tier 1 Capital reported in item 7.Memorandum Items: Common Equity Tier 1 CapitalItem 7 | Report in item 7 the Common Equity Tier 1 Capital as at the end of the period.
Sourced from the Federal Register of Legislation at legislation.gov.au, © Commonwealth of Australia, licensed under CC BY 4.0. Compilations may have been reformatted.